<code id='2B5AD0810D'></code><style id='2B5AD0810D'></style>
    • <acronym id='2B5AD0810D'></acronym>
      <center id='2B5AD0810D'><center id='2B5AD0810D'><tfoot id='2B5AD0810D'></tfoot></center><abbr id='2B5AD0810D'><dir id='2B5AD0810D'><tfoot id='2B5AD0810D'></tfoot><noframes id='2B5AD0810D'>

    • <optgroup id='2B5AD0810D'><strike id='2B5AD0810D'><sup id='2B5AD0810D'></sup></strike><code id='2B5AD0810D'></code></optgroup>
        1. <b id='2B5AD0810D'><label id='2B5AD0810D'><select id='2B5AD0810D'><dt id='2B5AD0810D'><span id='2B5AD0810D'></span></dt></select></label></b><u id='2B5AD0810D'></u>
          <i id='2B5AD0810D'><strike id='2B5AD0810D'><tt id='2B5AD0810D'><pre id='2B5AD0810D'></pre></tt></strike></i>

          Home / Wikipedia / hotspot

          hotspot


          hotspot

          author:comprehensive    Page View:64
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In